{"id": "chatcmpl-8JaKGnbizSdxPae2mBlZNDbXxB7Yy", "object": "chat.completion", "created": 1699678560, "model": "gpt-4-0613", "choices": [{"index": 0, "message": {"role": "assistant", "content": "1. TEAEs occurred in \u2265 5% of participants.\n2. Some TEAEs were reported at two or more times the rate of placebo.\n3. Decreased appetite was a TEAE reported in the forced-dose study.\n4. Decreased weight was a TEAE reported in the forced-dose study.\n5. Insomnia was a TEAE reported in the forced-dose study.\n6. Initial insomnia was a TEAE reported in the forced-dose study.\n7. Dry mouth was a TEAE reported in the forced-dose study.\n8. Nasopharyngitis was a TEAE reported in the forced-dose study.\n9. Irritability was a TEAE reported in the forced-dose study.\n10. Dizziness was a TEAE reported in the forced-dose study.\n11. Increased heart rate was a TEAE reported in the forced-dose study.\n12. Decreased appetite was a TEAE reported in the flexible-dose study.\n13. Decreased weight was a TEAE reported in the flexible-dose study.\n14. Insomnia was a TEAE reported in the flexible-dose study.\n15. Dizziness was a TEAE reported in the flexible-dose study.\n16. Dry mouth was a TEAE reported in the flexible-dose study.\n17. Upper abdominal pain was a TEAE reported in the flexible-dose study.\n18. LDX and OROS-MPH were associated with decreased appetite, decreased weight, insomnia, and nasopharyngitis in the forced-dose study.\n19. LDX was associated with irritability and dizziness in the forced-dose study.\n20. OROS-MPH was associated with increased heart rate in the forced-dose study.\n21. LDX and OROS-MPH were associated with decreased appetite, decreased weight, insomnia, and dizziness in the flexible-dose study.\n22. LDX was associated with dry mouth and upper abdominal pain in the flexible-dose study."}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 149, "completion_tokens": 403, "total_tokens": 552}, "temperature": 0, "max_tokens": 512, "top_p": 1, "frequency_penalty": 0, "presence_penalty": 0, "messages": [{"role": "system", "content": "Statement: TEAEs occurring in \u2265 5% of participants that were also reported at two or more times the rate of placebo were decreased appetite, decreased weight, insomnia, initial insomnia, dry mouth, and nasopharyngitis (LDX and OROS-MPH), irritability and dizziness (LDX only), and increased heart rate (OROS-MPH only) in the forced-dose study and decreased appetite, decreased weight, insomnia, and dizziness (LDX and OROS-MPH) and dry mouth and upper abdominal pain (LDX only) in the flexible-dose study.\n\nList all the facts we explicitly know from the statement. Make each fact as atomic as possible."}]}